1887

Journal of General Virology header logo

Volume 73, Issue 1

Role of Epstein-Barr virus and interleukin 6 in the development of lymphomas of human origin in SCID mice engrafted with human tonsillar mononuclear cells Free

Abstract

Mice with severe combined immunodeficiency were inoculated intraperitoneally with 50 × 10 human tonsillar mononuclear cells (hu-TMCs) from Epstein-Barr virus (EBV) antibody seropositive or seronegative human subjects. Between 5 and 11 weeks later, 29.4% (10/34) of mice injected with hu-TMCs from EBV seropositive donors, but none of 34 animals receiving hu-TMCs from EBV seronegative donors, developed intraabdominal and/or intrathoracic tumours (, 0.002). By means of hybridization using alpha satellite DNA from human chromosome 17, all tumours produced after cell transfer from EBV seropositive donors were identified to be of human origin. Histologically the tumours resembled large cell lymphomas; the EBV genome was detected by hybridization and EBV nuclear antigen by immunofluorescence in these tumours. The tumours were poly- or oligoclonal, and stained for human IgG and IgM, and less frequently IgA and IgD. Serum levels of human immunoglobulin in animals developing human tumours were significantly higher than in reconstituted mice without tumours and the sera exhibited polyoligo- or monoclonality in immunoelectrophoresis. Human interleukin 6 was detected in the serum of six of 10 animals with human lymphomas, but not in any animals without human lymphoma.

  • Received:
  • Accepted:
  • Published Online:
© Journal of General Virology 1992
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-1-113
1992-01-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/1/JV0730010113.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-1-113&mimeType=html&fmt=ahah

References

  1. Allday M. J., Crawford D. H. 1988; Role of epithelium in EBV persistence and pathogenesis of B-cell tumours. Lancet i:855–857
     [Google Scholar]
  2. Andiman W. A., Eastman R., Kelsey M., Katz B. Z., Rubinstein A., Pitt J., Pahwa S., Miller G. 1985; Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS. Lancet ii:1390–1393
     [Google Scholar]
  3. Bankert R. B., Umemoto T., Sugiyama Y., Chen F. A., Repasky E., Yokota S. 1989; Human lung tumors, patient’s peripheral blood lymphocytes and tumor infiltrating lymphocytes propagated in Scid mice. Current Topics in Microbiology and Immunology 152:201–210
     [Google Scholar]
  4. Barry T. S., Jones D. M., Richter C. B., Haynes B. F. 1991; Successful engraftment of human postnatal thymus in severe combined immune deficient (SCID) mice: differential engraftment of thymic components with irradiation versus anti-asialo GM1 immunosuppressive regimens. Journal of Experimental Medicine 173:167–180
     [Google Scholar]
  5. Birx D. L., Redfield R., Tosato G. 1986; Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. New England Journal of Medicine 314:874–879
     [Google Scholar]
  6. Bosma G. C., Custer R. P., Bosma M. J. 1983; A severe combined immunodeficiency mutation in the mouse. Nature, London 301:527–530
     [Google Scholar]
  7. Bosseloir A., Hooghe-Peters E. L., Heinen E., Cormann N., Kinet-Denoel C., Vanhaelst L., Simar L. 1989; Localization of interleukin 6 mRNA in human tonsils by in situ hybridization. European Journal of Immunology 19:2379–2381
     [Google Scholar]
  8. Brown N. A. 1987; The Epstein-Barr virus (infectious mononucleosis, B-lymphoproliferative disorders). In Pediatric Infectious Diseases 2nd edn. vol 2 pp 1566–1577 Edited by Feigin R., Cherry J. Philadelphia: W. B. Saunders;
     [Google Scholar]
  9. Cannon M. J., Pisa P., Fox R. I., Cooper N. R. 1990; Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice. Journal of Clinical Investigation 85:1333–1337
     [Google Scholar]
  10. Chen C., Nadal D., Cohen S., Mookerjee B., Vladutiu A., Stinson M., Ogra P. L., Albini B. 1991; Direct demonstration of engraftment of human peripheral blood leukocytes (hu-PBL) in scid mice.. International Archives of Allergy and Applied Immunology (in press)
    [Google Scholar]
  11. Cleary M. L., Warnke R., Sklar J. 1984; Monoclonality of lymphoproliferative lesions in cardiac transplant recipients. New England Journal of Medicine 310:477–482
     [Google Scholar]
  12. Dambaugh T., Beisel C., Hummel M., King W., Fennewald S., Cheung A., Heller M., Raab-Traub N., Kieff E. 1980; Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping. Proceedings of the National Academy of Sciences, U.S.A. 77:2999–3003
     [Google Scholar]
  13. De Thé G., Geser A., Day N. E., Tukei P. M., Williams E. H., Beri D. P., Smith P. G., Dean A. G., Bornkamm G. W., Feorino P., Henle W. 1978; Epidemiological evidence for causal relationships between Epstein-Barr virus and Burkitt’s lymphoma from Ugandan prospective study. Nature, London 274:756–761
     [Google Scholar]
  14. Duchosal M. A., McConahey P. J., Robinson C. A., Dixon F. J. 1990; Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice. Journal of Experimental Medicine 172:985–988
     [Google Scholar]
  15. Greenspan J. S., Greenspan D., Lenette E. T., Abrams D. I., Conant M. A., Peterson V., Freese U. K. 1985; Replication of Epstein-Barr virus within the epithelial cells of oral ‘hairy’ leukoplakia, an AIDS-associated lesion. New England Journal of Medicine 313:1564–1571
     [Google Scholar]
  16. Hamilton-Dutoit S. J., Pallesen G., Franzman M. B., Karkov J., Black F., Skinhoj P., Pedersen C. 1991; AIDS-related lymphoma Histopathology, immunophenotype and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. American Journal of Pathology 138:149–163
     [Google Scholar]
  17. Hanto D. W., Frizzera G., Gajl-Peczalska K. J., Sakamoto K., Purtilo D. T., Balfour H. H., Simmons R. L., Najarian J. S. 1982; Epstein-Barr virus-induced B-cell lymphoma after renal transplantation. Acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. New England Journal of Medicine 306:913–918
     [Google Scholar]
  18. Harabuchi Y., Yamanaka N., Kataura A., Imai S., Kinoshita T., Mizuno F., Osato T. 1990; Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet ii:128–130
     [Google Scholar]
  19. Henle W., Henle G., Horowitz C. A. 1974; Epstein-Barr virus specific diagnostic tests in infectious mononucleosis. Human Pathology 5:551
     [Google Scholar]
  20. Hirano T., Yasukawa K., Harada H., Taga T., Watanabe Y., Matsuda T., Kashiwamura S., Nakajima K., Koyama K., Iwamatsu A., Tsunasawa S., Sakiyama F., Matsui H., Takahara Y., Taniguchi T., Kishimoto T. 1986; Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature, London 324:73–76
     [Google Scholar]
  21. Hirano T., Akira S., Taga T., Kishimoto T. 1990; Biological and clinical aspects of interleukin 6. Immunology Today 11:443–449
     [Google Scholar]
  22. Ho M., Miller G., Atchinson W., Breinig M. K., Dummer J. S., Andiman W., Starzl T., Eastman R., Griffith B. P., Hardesty R. L., Bahnson H. T., Hakal T. R., Rosenthal J. T. 1985; Epstein-Barr virus infections and DNA hybridization studies in post transplantation lymphoma and lymphoproliferative lesions: the role of primary infection. Journal of Infectious Diseases 152:876–886
     [Google Scholar]
  23. Jones J. F., Shurin S., Abramowsky C., Tubbs R. R., Sciottio C. G., Wahl R., Sands J., Gottman D., Katz B. Z., Sklar J. 1988; T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr infections. New England Journal of Medicine 318:733–741
     [Google Scholar]
  24. Kawano M., Hirano T., Matsuda T., Taga T., Horii Y., Iwato K., Asaoku H., Tang B., Tanabe O., Tanaka H., Kuramoto A., Kishimoto T. 1988; Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature, London 332:83–85
     [Google Scholar]
  25. Klein B., Zhang X.-G., Jourdan M., Content J., Houssiau F., Aarden L., Piechaczyk M., Bataille R. 1989; Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 73:517–526
     [Google Scholar]
  26. Kramer M. (editor) 1988 Clinical Epidemiology and Biostatistics New York: Springer-Verlag;
     [Google Scholar]
  27. Krams S. M., Dorshkind K., Gershwin M. E. 1989; Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice. Journal of Experimental Medicine 170:1919–1930
     [Google Scholar]
  28. McCune J. M., Namikawa R., Kaneshima H., Shultz L. D., Lieberman M., Weissman I. L. 1988; The Scid-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632–1639
     [Google Scholar]
  29. Miller G. 1985; Epstein-Barr virus. In Virology pp 563–589 Edited by Fields B. N. New York: Raven Press;
     [Google Scholar]
  30. Mosier D. E., Gulizia R. J., Baird S. M., Wilson D. B. 1988; Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature, London 335:256–259
     [Google Scholar]
  31. Miraguchi A., Hirano T., Tang B., Matsuda T., Horii Y., Nakajima K., Kishimoto T. 1988; The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. Journal of Experimental Medicine 167:332–344
     [Google Scholar]
  32. Nadal D., Albini B., Chen C., Schläapfer E., Bernstein J. M., Ogra P. L. 1991a; Distribution and engraftment of human tonsillar mononuclear cells and immunoglobulin secreting cells in mice with severe combined immunodeficiency. The role of Epstein-Barr virus.. International Archives of Allergy and Applied Immunology (in press)
    [Google Scholar]
  33. Nadal D., Albini B., Schläpfer E., Chen C., Brodsky L., Ogra P. L. 1991b; Tissue distribution of mucosal antibody producing cells specific for respiratory syncytial virus in scid mice engrafted with human tonsils. Clinical and Experimental Immunology (in press)
    [Google Scholar]
  34. Okamoto Y., Brodsky L., Bernstein J. M., Ogra P. L. 1988; Characteristics of in vitro production of mucosal antibody to respiratory syncytial virus in tonsillar tissue lymphocytes. Clinical Immunology and Immunopalhology 49:299–307
     [Google Scholar]
  35. Okano M., Taguchi Y., Nakamine H., Pirruccello S. J., Davis J. R., Beisel K. W., Kleveland K. L., Sanger W. G., Fordyce R. R., Purtilo D. T. 1990; Characterization of Epstein-Barr virus-induced lymphoproliferation derived from human peripheral blood mononuclear cells transferred to severe combined immunodeficient mice. American Journal of Pathology 137:517–522
     [Google Scholar]
  36. Pallesen G., Hamilton-Dutoit S. J., Rowe M., Young L. S. 1991; Expression of Epstein-Barr virus latent gene products in tumor cells of Hogkin’s disease. Lancet ii:320–322
     [Google Scholar]
  37. Pinkel D., Straume T., Gray J. W. 1986; Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proceedings of the National Academy of Sciences, U.S.A 83:2934–2938
     [Google Scholar]
  38. Purtilo D. T., Sakamoto K., Bernabei V., Seeley J., Bechtold T., Rogers G., Yetz J., Harada S. 1982; Epstein-Barr virus-induced diseases in boys with X-linked lymphoproliferative syndrome (XLP). American Journal of Medicine 73:49–56
     [Google Scholar]
  39. Purtilo D. T., Falk K., Pirruccello S. J., Nakamine H., Kleveland K., Davis J. R., Okano M., Taguchi Y., Sanger W. G., Beisel K. W. 1991; SCID mouse model of Epstein-Barr virus-induced lymphomagenesis of immunodeficient humans. International Journal of Cancer 47:510–517
     [Google Scholar]
  40. Rowe M., Young L. S., Crocker J., Stokes H., Henderson S., Rickinson A. B. 1991; Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. Journal of Experimental Medicine 173:147–158
     [Google Scholar]
  41. Saxon A., Macy E., Denis K., Tary-Lehman M., Witte O., Braun J. 1991; Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans. Journal of Clinical Investigation 87:658–665
     [Google Scholar]
  42. Scala G., Quinto I., Ruocco M. R., Arcucci A., Mallardo M., Caretto P., Forni G., Venuta S. 1990; Expression of an exogenous interleukin 6 gene in human Epstein-Barr virus B cells confers growth advantage and in vivo tumorigenicity.. Journal of Experimental Medicine 172:61–68
     [Google Scholar]
  43. Shapiro R. S., McClain K., Frizzera G., Gajl-Peczalska K. J., Kersey J. H., Blazar B. R., Arthur D. C., Patton D. F., Greenberg J. S., Burke B., Ramsay N. K. C., McGlave P., Filipovich A. H. 1988; Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 71:1234–1243
     [Google Scholar]
  44. Stansfield A. G., Diebold J., Noel H., Kapanci Y., Rilke F., Kelénxi G., Sundstrom C., Lennert K., van Unnik J. A. M., Mioduszewska O., Wright D. H. 1988; Updated Kiel classification for lymphomas. Lancet i:292–293
     [Google Scholar]
  45. Swinnen L. J., Costanzo-Nordin M. R., Fisher S. G., O’Sullivan E. J., Johnson M. R., Heroux A. L., Dizikes G. J., Pifarre R., Fisher R. I. 1990; Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. New England Journal of Medicine 323:1723–1728
     [Google Scholar]
  46. Talacko A. A., Teo C. G., Griffin B. E., Johnson N. W. 1991; Epstein-Barr virus receptors but not viral DNA are present in normal and malignant oral epithelium. Journal of Oral Pathology and Medicine 20:20–25
     [Google Scholar]
  47. Tighe H., Silverman G. J., Kozin F., Tucker R., Gulizia R., Peebles C., Lotz M., Rhodes G., Machold K., Mosier D. E., Carson D. A. 1990; Autoantibody production by severe combined immunodeficient mice reconstituted with synovial cells from rheumatoid arthritis patients. European Journal of Immunology 20:1843–1848
     [Google Scholar]
  48. Tohyama N., Karasuyama H., Tada T. 1990; Growth autonomy and tumorigenicity of interleukin 6-dependent B cells transfected with interleukin 6 cDNA. Journal of Experimental Medicine 171:389–400
     [Google Scholar]
  49. Tosato G., Gerrard T. L., Goldman N. G., Pike S. E. 1988; Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-β 2/B cell stimulatory factor 2/IL-6. Journal of Immunology 140:4329–4336
     [Google Scholar]
  50. Van Snick J. 1990; Interleukin-6: an overview. Annual Review of Immunology 8:253–278
     [Google Scholar]
  51. Vink A., Coulie P., Warnier G., Renauld J.-C., Stevens M., Donekers D., Van Snick J. 1990; Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor. Journal of Experimental Medicine 172:997–1000
     [Google Scholar]
  52. Virelizier J.-L., Lenoir G., Griscelli C. 1978; Persistent Epstein-Barr virus infection in a child with hypergammaglobulinemia and immunoblastic proliferation associated with a selective defect in immune interferon secretion. Lancet ii:231–234
     [Google Scholar]
  53. Waye J. S., Willard H. F. 1986; Structure, organization, and sequence of alpha satellite DNA from human chromosome 17: evidence for evolution by unequal cross-over and ancestral pentamer repeat shared with the human X chromosome. Molecular and Cellular Biology 3:3156–3165
     [Google Scholar]
  54. Yamanaka N., Harabuchi Y., Sambe S., Shido F., Matsuda F., Kataura A., Ishii Y., Kikuchi K. 1985; Non-Hodgkin’s lymphoma of Waldeyer’s ring and nasal cavity. Clinical and immunologic aspects. Cancer 56:768–776
     [Google Scholar]
  55. Young L. S., Clark D., Sixbey J. W., Rickinson A. B. 1986; Epstein-Barr virus receptors on human pharyngeal epithelia. Lancet i:240–242
     [Google Scholar]
  56. Young L. S., Dawson C. W., Clark D., Rupani H., Busson P., Tursz T., Johnson A., Rickinson A. B. 1988; Epstein-Barr virus gene expression in nasopharyngeal carcinoma. Journal of General Virology 69:1051–1065
     [Google Scholar]
  57. Zhang X. G., Klein B., Bataille R. 1989; Interleukin-6 is a potent myeloma growth cell factor in patients with aggressive multiple myeloma. Blood 74:11–13
     [Google Scholar]
  58. Zutter M. M., Martin P. J., Sale G. E., Shulman H. M., Fisher L., Thomas E. D., Durnam D. M. 1988; Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 72:520529
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-1-113
Loading
Role of Epstein-Barr virus and interleukin 6 in the development of lymphomas of human origin in SCID mice engrafted with human tonsillar mononuclear cells
J. Gen. Virol. 73, 113 (1992); https://doi.org/10.1099/0022-1317-73-1-113
/content/journal/jgv/10.1099/0022-1317-73-1-113
/content/journal/jgv/10.1099/0022-1317-73-1-113
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error